Tendonitis treatment Market Trends, Size, Competitive Analysis and Forecast 2022-2028

The global tendonitis treatment market is anticipated to grow at a considerable CAGR of % during the forecast period. Achilles tendonitis can be treated with both conservative and surgical methods, depending on whether the condition is acute or chronic. The surgical treatment approach is highly recommended by professionals in the case of individuals who have a full rupture. According to the NCBI article titled 'Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People,' the lifetime incidence of Achilles Tendonitis in athletes is expected to be around 24.0% in 2021. Furthermore, it has been reported that elite adolescent athletes had an Achilles tendinopathy frequency of 1.0% to 2.0%, whereas recreational athletes have an injury frequency of 9.0%.

To Request a Sample of our Report on Tendonitis treatment Market: https://www.omrglobal.com/request-sample/tendonitis-treatment-market

Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in January 2018, MiMedx biopharmaceutical company developing therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare announced that the first patients have been randomized and enrolled in the Company's Phase 3 Investigational New Drug (IND) clinical trial for MiMedx's micronized amniotic tissue, AmnioFix Injectable, in the treatment of Achilles Tendonitis. The company was pleased to enroll their first patients in this important Phase 3 IND study in the Orthopedic/Sports Medicine area and this as a result will enable them to address the unmet need in the market for Achilles tendonitis treatment.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Condition

· By Treatment

Regions Covered

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- DJO Global Inc., Zimmer Biomet, 3M Co, and AKSIGEN, and others.

(Get 15% Discount on Buying this Report)

A full Report of Tendonitis treatment Market is Available @ https://www.omrglobal.com/industry-reports/tendonitis-treatment-market

Global Tendonitis Treatment Market Report by Segment

By Condition

• Achilles Tendonitis

• Supraspinatus Tendonitis

• Tennis Elbow

• Golfer's Elbow

• Pitcher's Elbow

By Treatment

• Surgical Treatment

• Physical therapy

• Shockwave Therapy

• Others (Hot and Cold Therapy)

Global Tendonitis Treatment Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· 3M Co

· Abbott

· Aksigen Hospital Care

· Almatica Pharma, Inc.

· AstraZeneca

· Bayer AG

· Boehringer Ingelheim Pharmaceuticals, Inc.

· DJO Global, Inc.

· GlaxoSmithKline PLC

· Integra Life Sciences Corp

· Merck and Co., Inc.

· Össur hf.

· Pfizer

· Replicel Life Sciences

· Smith+Nephew

· Stryker Corp

· Teikoku Pharma USA, Inc

· Teva Pharmaceuticals Industries

· Tynor Orthotics Private Limited

· Zimmer Biomet

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.